Research
Hormonal
Tirzepatide use is associated with a significantly increased incidence of adverse reactions, particularly gastrointestinal issues like nausea and diarrhea, which are dose-dependent.
Be prepared for potential side effects when starting Tirzepatide. Nausea and diarrhea are common, especially when you first start or increase the dose. These symptoms often improve over time. Starting at a lower dose (2.5mg) and gradually increasing can help your body adjust. Most people find the side effects manageable.
StrongQualifiesHIGH confidence
The total incidence of adverse reactions in Tirzepatide vs control was significantly increased (Odds Ratio (OR): 1.57, 95%CI: 1.35 to 1.81)... presented a dose dependent effect (5mg: OR: 1.40... 15mg: OR: 1.73).
Why this rating
Meta-analysis of 11 RCTs.
Source
Efficacy and Safety of Tirzepatide in Overweight and Obese Individuals: A Meta-Analysis of Randomized Controlled Trials
Liya Fu et al. · Medical Research Frontiers · 2026
DOI 10.57237/j.mrf.2025.04.001
Meta-analysis · 11 studies
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Tirzepatide administration significantly reduces body weight in overweight and obese individuals (BMI ≥28 kg/m²) compared to control, with the magnitude of weight loss being dose-dependent.Strong
- Tirzepatide significantly reduces HbA1c levels in individuals with Type 2 Diabetes, with the effect being dose-dependent.Strong
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →